BusinessPhoto: Business StandardGland Pharma Q2 FY27 Net Profit Rises 58% to ₹290.75 Crore
Gland Pharma reported a 58.29% rise in consolidated net profit to ₹290.75 crore for the September quarter, up from ₹183.68 crore a year ago. Revenue increased to ₹1,833.58 crore from ₹1,486.87 crore. The company launched four molecules in the US and saw 31% growth in its CDMO business, driven by strategic partnerships and expanded customer engagements.
Business Standard·



